Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4294672
Max Phase: Preclinical
Molecular Formula: C10H17N3O2S
Molecular Weight: 243.33
Molecule Type: Small molecule
Associated Items:
ID: ALA4294672
Max Phase: Preclinical
Molecular Formula: C10H17N3O2S
Molecular Weight: 243.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC1(CC)SC(NC(C)=O)=NN1C(C)=O
Standard InChI: InChI=1S/C10H17N3O2S/c1-5-10(6-2)13(8(4)15)12-9(16-10)11-7(3)14/h5-6H2,1-4H3,(H,11,12,14)
Standard InChI Key: WSLDUSCDNPSPRD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 243.33 | Molecular Weight (Monoisotopic): 243.1041 | AlogP: 1.51 | #Rotatable Bonds: 2 |
Polar Surface Area: 61.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.69 | CX Basic pKa: | CX LogP: 1.36 | CX LogD: 1.36 |
Aromatic Rings: 0 | Heavy Atoms: 16 | QED Weighted: 0.80 | Np Likeness Score: -0.99 |
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |
Source(1):